Cargando...
Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy
Despite the advent of immune checkpoint blockade for effective treatment of advanced malignancies, only a minority of patients respond to therapy and significant immune-related adverse events remain to be minimized. Innovations in engineered drug delivery systems and controlled release strategies ca...
Gardado en:
| Publicado en: | Adv Drug Deliv Rev |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5581991/ https://ncbi.nlm.nih.gov/pubmed/28455187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2017.04.011 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|